Verastem (VSTM) Cash from Operations Growth (3y) (2014 - 2026)
Verastem (VSTM) Cash from Operations Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | -5.07% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn | 33.08% |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | 16.64% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn | -7.60% |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Verastem | 613.34 Mn | 415.52 Mn | 15.90 Mn | -36.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.96% |
| Dec 31, 2025 | -21.71% |
| Sep 30, 2025 | -33.91% |
| Jun 30, 2025 | -37.03% |
| Mar 31, 2025 | -26.12% |
| Dec 31, 2024 | -36.20% |
| Sep 30, 2024 | -30.01% |
| Jun 30, 2024 | -27.11% |
| Mar 31, 2024 | -13.58% |
| Dec 31, 2023 | -11.00% |
| Sep 30, 2023 | -33.34% |
| Jun 30, 2023 | 4.07% |
| Mar 31, 2023 | 15.82% |
| Dec 31, 2022 | 23.57% |
| Sep 30, 2022 | 18.49% |
| Jun 30, 2022 | 28.46% |
| Mar 31, 2022 | 20.78% |
| Dec 31, 2021 | 19.71% |
| Sep 30, 2021 | 21.71% |
| Jun 30, 2021 | -9.19% |